Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

John Paulson’s 10 New Stock Picks

John Paulson is the most successful hedge fund manager of the past four years. He made $4 billion by betting against subprime mortgage investments in 2007 and another $5 billion by betting on gold and the recovery of the economy in 2010. His gold investments are his savior in 2011 as well. Paulson’s Paulson & Co. manages separate client-focused portfolios, employing merger arbitrage, long/short, and event-driven strategies. Paulson uses fundamental analysis to make his investments.

best gold ETF

During the second quarter John Paulson dumped half of his stake in Bank of America (BAC) and Comcast (CMCSA). Each of these transactions were about $600 Million. Paulson also sold a fifth of his stake in Citigroup (C). This transaction was than $300 Million. What did Paulson buy with the proceeds from these transactions? Here are John Paulson’s 10 new stock picks:

1. LIFE TECHNOLOGIES CORP (LIFE): $392 Million

2. SAVVIS INC (SVVS): $225 Million

3. NEWS CORP (NWSA): $184 Million

4. SOUTHERN UN CO (SUG): $182 Million

5. MOSAIC CO (MOS): $152 Million

6. TENET HEALTHCARE CORP (THC): $125 Million

7. WALTER ENERGY INC (WLT): $116 Million

8. GRIFOLS S A (GRFS): $107 Million

9. NYSE EURONEXT (NYX): $103 Million

10. MGM RESORTS INTL  Bonds (MGM): $83 Million

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!